businesspress24.com - MTBC Declares Monthly Dividends on Non-Convertible Series A Cumulative Redeemable Perpetual Preferre
 

MTBC Declares Monthly Dividends on Non-Convertible Series A Cumulative Redeemable Perpetual Preferred Stock Offering

ID: 1493533

(firmenpresse) - SOMERSET, NJ -- (Marketwired) -- 03/20/17 -- (NASDAQ: MTBC) (NASDAQ: MTBCP), a leading provider of proprietary web-based electronic health records, practice management and mHealth solutions, announced today that its Board of Directors has declared monthly cash dividends for its 11% Series A Cumulative Redeemable Perpetual Preferred Stock ("Series A Preferred Stock") for March, April and May 2017.

Holders of shares of the Series A Preferred Stock are entitled to receive cumulative cash dividends at the rate of 11% of the $25.00 per share liquidation preference per annum (equivalent to $2.75 per annum per share). Dividends on the Series A Preferred Stock are payable monthly on the 15th day of each month; provided that if any dividend payment date is not a business day, then the dividend may be paid on the next succeeding business day. Dividends are payable to holders of record on the applicable record date, which shall be the last day of the calendar month, whether or not a business day.

MTBC''s Series A Preferred Stock trades on the NASDAQ Capital Market under the ticker symbol "MTBCP."

The following table shows the monthly dividends and associated record and payment dates:





Medical Transcription Billing, Corp. is a healthcare information technology company that provides a fully integrated suite of proprietary web-based solutions, together with related business services, to healthcare providers throughout the United States. Our integrated Software-as-a-Service (or SaaS) platform helps our customers increase revenues, streamline workflows and make better business and clinical decisions, while reducing administrative burdens and operating costs. MTBC''s common stock trades on the NASDAQ Capital Market under the ticker symbol "MTBC," and its Series A Preferred Stock trades on the NASDAQ Capital Market under the ticker symbol "MTBCP."

For additional information, please visit our website at .




Follow MTBC on , and .

SOURCE MTBC

This press release is for information purposes only, and does not constitute an offer to sell or solicitation of an offer to buy, nor shall there be any sale of these securities in any state or other jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of such state or jurisdiction.



:
Christine J. Petraglia
Managing Director
PCG Advisory Group

(646) 731-9817

:
Bill Korn
Chief Financial Officer
Medical Transcription Billing, Corp.

(732) 873-5133

Weitere Infos zu dieser Pressemeldung:

Themen in dieser Pressemitteilung:


Unternehmensinformation / Kurzprofil:



Leseranfragen:



PresseKontakt / Agentur:



drucken  als PDF  an Freund senden  Nemus Bioscience Signs Development Agreement with Nanomerics to Advance Ocular Formulation of NB1111 for the Treatment of Glaucoma Using Proprietary Molecular Envelope Technology (MET)
eWellness Plans East Coast Regional Support Team For PT Clinic Adoption
Bereitgestellt von Benutzer: Marketwired
Datum: 20.03.2017 - 07:30 Uhr
Sprache: Deutsch
News-ID 1493533
Anzahl Zeichen: 3509

contact information:
Contact person:
Town:

SOMERSET, NJ


Phone:

Kategorie:

Venture Capital


Typ of Press Release:
type of sending:
Date of sending:
Anmerkungen:


Diese Pressemitteilung wurde bisher 167 mal aufgerufen.


Die Pressemitteilung mit dem Titel:
"MTBC Declares Monthly Dividends on Non-Convertible Series A Cumulative Redeemable Perpetual Preferred Stock Offering
"
steht unter der journalistisch-redaktionellen Verantwortung von

Medical Transcription Billing, Corp. (Nachricht senden)

Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).


Alle Meldungen von Medical Transcription Billing, Corp.



 

Who is online

All members: 10 562
Register today: 1
Register yesterday: 2
Members online: 0
Guests online: 68


Don't have an account yet? You can create one. As registered user you have some advantages like theme manager, comments configuration and post comments with your name.